ACEI and ARB - Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation

Mayo Clin Proc. 2023 Feb;98(2):350-351. doi: 10.1016/j.mayocp.2022.11.017.

Authors

Martin H Strauss¹, Alistair S Hall², Krzysztof Narkiewicz³

Affiliations

¹ University of Toronto, North York General Hospital, Toronto, Ontario, Canada.
² Leeds School of Medicine, University of Leeds, United Kingdom.
³ Medical University of Gdansk, Gdansk, Poland.

PMID: 36737125
DOI: 10.1016/j.mayocp.2022.11.017

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiotensin Receptor Antagonists / adverse effects
Angiotensin-Converting Enzyme Inhibitors* / adverse effects
Humans
Inflammation / drug therapy
Renin-Angiotensin System*

Substances

Angiotensin-Converting Enzyme Inhibitors
Angiotensin Receptor Antagonists